Resolvin D1 promotes efferocytosis in aging by limiting senescent cell-induced MerTK cleavage
Nicholas Rymut1, Justin Heinz1, Sudeshna Sadhu1
1The Department of Molecular and Cellular Physiology, Albany Medical College, Albany, NY, USA.
Abstract:
Inflammation-resolution is mediated by the balance between specialized pro-resolving mediators (SPMs) like resolvin D1 (RvD1) and pro-inflammatory factors, like leukotriene B4 (LTB4). A key cellular process of inflammation-resolution is efferocytosis. Aging is associated with defective inflammation-resolution and the accumulation of pro-inflammatory senescent cells (SCs). Therefore, understanding mechanism(s) that underpin this impairment is a critical gap. Here, using a model of hind limb ischemia-reperfusion (I/R) remote lung injury, we present evidence that aging is associated with heightened inflammation, impaired SPM:LT ratio, defective efferocytosis, and a decrease in MerTK levels in injured lungs. Treatment with RvD1 mitigated I/R lung injury in aging, promoted efferocytosis, and prevented the decrease of MerTK in injured lungs from old mice. Old MerTK cleavage-resistant mice (MerTKCR) exhibited less neutrophils or polymorpho nuclear cells infiltration and had improved efferocytosis compared with old WT controls. Mechanistically, macrophages that were treated with conditioned media (CM) from senescent cells had increased MerTK cleavage, impaired efferocytosis, and a defective RvD1:LTB4 ratio. Macrophages from MerTKCR mice were resistant to CM-induced efferocytosis defects and had an improved RvD1:LTB4 ratio. RvD1-stimulated macrophages prevented CM-induced MerTK cleavage and promoted efferocytosis. Together, these data suggest a new mechanism and a potential therapy to promote inflammation-resolution and efferocytosis in aging.
Insights
Aging impairs inflammation resolution and efferocytosis due to reduced MerTK. Resolvin D1 (RvD1) therapy and MerTK cleavage resistance restore these functions, offering potential treatments for age-related inflammatory conditions.
Area of Science:
- Immunology
- Aging Research
- Molecular Biology
Background:
- Inflammation resolution depends on specialized pro-resolving mediators (SPMs) and pro-inflammatory factors, with efferocytosis being a key process.
- Aging is linked to impaired inflammation resolution, accumulation of senescent cells, and defective efferocytosis.
- Understanding the mechanisms behind aging-related inflammation resolution deficits is crucial.
Purpose of the Study:
- To investigate the mechanisms underlying impaired inflammation resolution and efferocytosis in aging.
- To explore the role of MerTK (Mer tyrosine kinase) in aging-related inflammation and efferocytosis.
- To evaluate the therapeutic potential of Resolvin D1 (RvD1) and MerTK modulation in aging models.
Main Methods:
- Utilized a hind limb ischemia-reperfusion (I/R) model to induce remote lung injury in aging mice.
- Assessed inflammation markers, SPM:LT ratio, efferocytosis, and MerTK levels in injured lungs.
- Employed senescent cell conditioned media (CM) to study macrophage efferocytosis defects in vitro.
- Utilized MerTK cleavage-resistant (MerTK CR) mice to investigate MerTK's role.
Main Results:
- Aging led to heightened lung inflammation, impaired RvD1:LTB4 ratio, defective efferocytosis, and decreased MerTK levels post-I/R.
- RvD1 treatment mitigated lung injury in aged mice, enhanced efferocytosis, and preserved MerTK levels.
- MerTK CR mice showed reduced neutrophil infiltration and improved efferocytosis compared to aged wild-type controls.
- Senescent cell CM impaired macrophage efferocytosis and increased MerTK cleavage, which was prevented in MerTK CR macrophages and by RvD1 stimulation.
Conclusions:
- Aging impairs inflammation resolution and efferocytosis through mechanisms involving increased MerTK cleavage induced by senescent cells.
- RvD1 therapy and MerTK cleavage resistance represent potential strategies to restore efferocytosis and promote inflammation resolution in aging.
- These findings highlight a novel therapeutic target for age-related inflammatory diseases.
Related Concept Videos
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
Mitochondria
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
Replicative Cell Senescence
Maturation of Endosomes
Changes in location
The maturing endosome moves along microtubules from the periphery of the cell towards the perinuclear region. This movement of the...
Export of Misfolded Proteins out of the ER


